The modified Glasgow prognostic score is a reliable predictor of oncological outcomes in patients with rectal cancer undergoing neoadjuvant chemoradiotherapy
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- Extent
-
1 Online-Ressource.
- Language
-
Englisch
- Bibliographic citation
-
The modified Glasgow prognostic score is a reliable predictor of oncological outcomes in patients with rectal cancer undergoing neoadjuvant chemoradiotherapy ; volume:13 ; number:1 ; day:10 ; month:10 ; year:2023 ; pages:1-8 ; date:12.2023
Scientific reports ; 13, Heft 1 (10.10.2023), 1-8, 12.2023
- Creator
-
Shimada, Atsushi
Matsuda, Takeru
Sawada, Ryuichiro
Hasegawa, Hiroshi
Yamashita, Kimihiro
Harada, Hitoshi
Urakawa, Naoki
Goto, Hironobu
Kanaji, Shingo
Oshikiri, Taro
Kakeji, Yoshihiro
- Contributor
-
SpringerLink (Online service)
- DOI
-
10.1038/s41598-023-44431-w
- URN
-
urn:nbn:de:101:1-2024020112261111157276
- Rights
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
27.02.2026, 6:28 AM CET
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Shimada, Atsushi
- Matsuda, Takeru
- Sawada, Ryuichiro
- Hasegawa, Hiroshi
- Yamashita, Kimihiro
- Harada, Hitoshi
- Urakawa, Naoki
- Goto, Hironobu
- Kanaji, Shingo
- Oshikiri, Taro
- Kakeji, Yoshihiro
- SpringerLink (Online service)
Other Objects (12)
Meta-analysis of neoadjuvant chemotherapy versus neoadjuvant chemoradiotherapy for locally advanced rectal cancer
Can neoadjuvant chemoradiotherapy affect exfoliated cancer cells in colorectal cancer?
Neoadjuvant therapy in pancreatic cancer: what is the true oncological benefit?
Concurrent chemo-radiotherapy following neoadjuvant chemotherapy in locally advanced breast cancer
Outcomes of neoadjuvant chemoradiotherapy in Japanese locally advanced rectal carcinoma patients
Factors influencing downstaging after neoadjuvant long-course chemoradiotherapy in rectal carcinoma
Usefulness of close surveillance for rectal cancer patients after neoadjuvant chemoradiotherapy
Neoadjuvant chemotherapy followed by concurrent chemoradiotherapy versus concurrent chemoradiotherapy followed by adjuvant chemotherapy in locally advanced nasopharyngeal carcinoma
Comparing neoadjuvant long-course chemoradiotherapy with short-course radiotherapy in rectal cancer
Predictive value of proteomic markers for advanced rectal cancer with neoadjuvant chemoradiotherapy
Development of a reliable surgical quality assurance tool for gastrectomy in oncological trials
Oncological risk of proximal gastrectomy for proximal advanced gastric cancer after neoadjuvant chemotherapy
Meta-analysis of neoadjuvant chemotherapy versus neoadjuvant chemoradiotherapy for locally advanced rectal cancer
Can neoadjuvant chemoradiotherapy affect exfoliated cancer cells in colorectal cancer?
Neoadjuvant therapy in pancreatic cancer: what is the true oncological benefit?
Concurrent chemo-radiotherapy following neoadjuvant chemotherapy in locally advanced breast cancer
Outcomes of neoadjuvant chemoradiotherapy in Japanese locally advanced rectal carcinoma patients
Factors influencing downstaging after neoadjuvant long-course chemoradiotherapy in rectal carcinoma
Usefulness of close surveillance for rectal cancer patients after neoadjuvant chemoradiotherapy
Neoadjuvant chemotherapy followed by concurrent chemoradiotherapy versus concurrent chemoradiotherapy followed by adjuvant chemotherapy in locally advanced nasopharyngeal carcinoma
Comparing neoadjuvant long-course chemoradiotherapy with short-course radiotherapy in rectal cancer
Predictive value of proteomic markers for advanced rectal cancer with neoadjuvant chemoradiotherapy
Development of a reliable surgical quality assurance tool for gastrectomy in oncological trials
Oncological risk of proximal gastrectomy for proximal advanced gastric cancer after neoadjuvant chemotherapy
Meta-analysis of neoadjuvant chemotherapy versus neoadjuvant chemoradiotherapy for locally advanced rectal cancer
Can neoadjuvant chemoradiotherapy affect exfoliated cancer cells in colorectal cancer?
Neoadjuvant therapy in pancreatic cancer: what is the true oncological benefit?
Concurrent chemo-radiotherapy following neoadjuvant chemotherapy in locally advanced breast cancer
Outcomes of neoadjuvant chemoradiotherapy in Japanese locally advanced rectal carcinoma patients
Factors influencing downstaging after neoadjuvant long-course chemoradiotherapy in rectal carcinoma
Usefulness of close surveillance for rectal cancer patients after neoadjuvant chemoradiotherapy
Neoadjuvant chemotherapy followed by concurrent chemoradiotherapy versus concurrent chemoradiotherapy followed by adjuvant chemotherapy in locally advanced nasopharyngeal carcinoma
Comparing neoadjuvant long-course chemoradiotherapy with short-course radiotherapy in rectal cancer
Predictive value of proteomic markers for advanced rectal cancer with neoadjuvant chemoradiotherapy
Development of a reliable surgical quality assurance tool for gastrectomy in oncological trials